Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson
Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson [Yahoo! Finance]
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson